Alobaidallah, M.S.A.; GarcÃa, V.; Wellner, S.M.; Thomsen, L.E.; Herrero-Fresno, A.; Olsen, J.E.
Enhancing the Efficacy of Chloramphenicol Therapy for Escherichia coli by Targeting the Secondary Resistome. Antibiotics 2024, 13, 73.
https://doi.org/10.3390/antibiotics13010073
AMA Style
Alobaidallah MSA, GarcÃa V, Wellner SM, Thomsen LE, Herrero-Fresno A, Olsen JE.
Enhancing the Efficacy of Chloramphenicol Therapy for Escherichia coli by Targeting the Secondary Resistome. Antibiotics. 2024; 13(1):73.
https://doi.org/10.3390/antibiotics13010073
Chicago/Turabian Style
Alobaidallah, Mosaed Saleh A., Vanesa GarcÃa, Sandra M. Wellner, Line E. Thomsen, Ana Herrero-Fresno, and John Elmerdahl Olsen.
2024. "Enhancing the Efficacy of Chloramphenicol Therapy for Escherichia coli by Targeting the Secondary Resistome" Antibiotics 13, no. 1: 73.
https://doi.org/10.3390/antibiotics13010073
APA Style
Alobaidallah, M. S. A., GarcÃa, V., Wellner, S. M., Thomsen, L. E., Herrero-Fresno, A., & Olsen, J. E.
(2024). Enhancing the Efficacy of Chloramphenicol Therapy for Escherichia coli by Targeting the Secondary Resistome. Antibiotics, 13(1), 73.
https://doi.org/10.3390/antibiotics13010073